Financials data is unavailable for this security.
View more
Year on year International Biotechnology Trust 's revenues fell -86.38% from 44.54m to 6.07m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 38.88m to a loss of 1.17m.
| Gross margin | -2.88% |
|---|---|
| Net profit margin | -19.28% |
| Operating margin | -18.82% |
| Return on assets | -0.40% |
|---|---|
| Return on equity | -0.44% |
| Return on investment | -0.44% |
More ▼
Cash flow in GBPView more
In 2025, International Biotechnology Trust increased its cash reserves by 43.58%, or 4.55m. The company earned 28.63m from its operations for a Cash Flow Margin of 471.87%. In addition the company used on investing activities and also paid 23.93m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 7.39 |
|---|---|
| Tangible book value per share | 7.39 |
More ▼
Balance sheet in GBPView more
| Current ratio | 0.4365 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.1187 |
|---|---|
| Total debt/total capital | 0.1061 |
More ▼
Growth rates in GBP
Year on year, growth in dividends per share increased 11.73% while earnings per share excluding extraordinary items fell by -103.23%. The positive trend in dividend payments is noteworthy since only some companies in the Investment Services industry pay a dividend. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 4.38% |
|---|---|
| Div growth rate (5 year) | 5.05% |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -104.10 |
More ▼
